We used a MPLW515L MPN model characterized by extensive BM fibrosis, splenomegaly, leukocytosis and thrombocytosis, which shares the typical activation of JAK2 and MAPK signaling seen in Jak2V617F-driven models [18]. Here, JAK2 is linked to thrombocytosis disease.